These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33155791)

  • 1. Assessment and prevalence of concomitant chemo-radiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma.
    Minhas S; Sajjad A; Chaudhry RM; Zahid H; Shahid A; Kashif M
    Turk J Med Sci; 2021 Apr; 51(2):675-684. PubMed ID: 33155791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and Evolution of Acute Oral Complications in Patients Undergoing Radiochemotherapy Treatment for Head and Neck Squamous Cell Carcinoma.
    Palmieri M; Sarmento DJS; Falcão AP; Martins VAO; Brandão TB; Morais-Faria K; Ribeiro ACP; Hasséus B; Giglio D; Braz-Silva PH
    Ear Nose Throat J; 2021 Sep; 100(5_suppl):449S-455S. PubMed ID: 31619067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study.
    Sharma A; Rath GK; Chaudhary SP; Thakar A; Mohanti BK; Bahadur S
    Eur J Cancer; 2012 Apr; 48(6):875-81. PubMed ID: 21741230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of Oro-T oral rinse in oral mucositis during cancer radiotherapy and/or chemotherapy: Cumulative analysis of two studies.
    Koushik K; Janaki MG; Kumawat R; Paramesh R; Palaniyamma D
    J Cancer Res Ther; 2021; 17(6):1503-1509. PubMed ID: 34916385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
    Bentzen SM; Saunders MI; Dische S; Bond SJ
    Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily Time of Radiation Treatment Is Associated with Subsequent Oral Mucositis Severity during Radiotherapy in Head and Neck Cancer Patients.
    Gu F; Farrugia MK; Duncan WD; Feng Y; Hutson AD; Schlecht NF; Repasky EA; Antoch MP; Miller A; Platek A; Platek ME; Iovoli AJ; Singh AK
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):949-955. PubMed ID: 32098893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of an ayurvedic preparation of yashtimadhu (
    Mamgain RK; Gupta M; Mamgain P; Verma SK; Pruthi DS; Kandwal A; Saini S
    J Cancer Res Ther; 2020; 16(3):458-462. PubMed ID: 32719251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of oral mucositis in patients who have cancer.
    Lalla RV; Sonis ST; Peterson DE
    Dent Clin North Am; 2008 Jan; 52(1):61-77, viii. PubMed ID: 18154865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
    Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
    Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review.
    Trotti A; Bellm LA; Epstein JB; Frame D; Fuchs HJ; Gwede CK; Komaroff E; Nalysnyk L; Zilberberg MD
    Radiother Oncol; 2003 Mar; 66(3):253-62. PubMed ID: 12742264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy.
    Adamietz IA; Rahn R; Böttcher HD; Schäfer V; Reimer K; Fleischer W
    Support Care Cancer; 1998 Jul; 6(4):373-7. PubMed ID: 9695205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of recombinant human epidermal growth factor (rhEGF) in a murine model of concurrent chemo- and radiotherapy-induced oral mucositis.
    Ryu SH; Kang KM; Moon SY; Chai GY; Hong JP; Cho KO; Kang MI; Choi EK; Lee SW
    J Radiat Res; 2010; 51(5):595-601. PubMed ID: 20921827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of Oral Mucositis with Iodine Solution during Concurrent Chemoradiation of Head and Neck Cancer: Preliminary Results of a Double-Blind, Randomized Controlled Trial.
    Namuangchan Y; Chailertwanich O; Susinsamphan S; Supakalin N; Supaadirek C; Krusun S; Pesee M; Thamronganantasakul K
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2445-2454. PubMed ID: 37505779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebamipide gargle in preventive management of chemo-radiotherapy induced oral mucositis.
    Chaitanya B; Pai KM; Yathiraj PH; Fernandes D; Chhaparwal Y
    Oral Oncol; 2017 Sep; 72():179-182. PubMed ID: 28797456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cytological Study Enlightening the Unseen Effects of Concomitant Chemoradiotherapy in Contralateral Normal Buccal Mucosa of Oral Squamous Cell Carcinoma Patients.
    Minhas S; Sajjad A; Noor M; Qureshi F; Khokhar RA; Kashif M
    Cureus; 2021 Apr; 13(4):e14483. PubMed ID: 34007739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a supersaturated calcium phosphate mouth rinse on the development of oral mucositis in head and neck cancer patients treated with (chemo)radiation: a single-center, randomized, prospective study of a calcium phosphate mouth rinse + standard of care versus standard of care.
    Lambrecht M; Mercier C; Geussens Y; Nuyts S
    Support Care Cancer; 2013 Oct; 21(10):2663-70. PubMed ID: 23686379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma.
    Cerchietti LC; Navigante AH; Bonomi MR; Zaderajko MA; Menéndez PR; Pogany CE; Roth BM
    Cancer; 2002 Nov; 95(10):2230-6. PubMed ID: 12412178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy.
    Bhide SA; Gulliford S; Fowler J; Rosenfelder N; Newbold K; Harrington KJ; Nutting CM
    Radiother Oncol; 2010 Oct; 97(1):86-91. PubMed ID: 20826031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis of oral mucositis associated with chemoradiotherapy for oral carcinoma by Azelastine hydrochloride (Azelastine) with other antioxidants.
    Osaki T; Ueta E; Yoneda K; Hirota J; Yamamoto T
    Head Neck; 1994; 16(4):331-9. PubMed ID: 8056578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer.
    Franco P; Martini S; Di Muzio J; Cavallin C; Arcadipane F; Rampino M; Ostellino O; Pecorari G; Garzino Demo P; Fasolis M; Airoldi M; Ricardi U
    Med Oncol; 2017 May; 34(5):81. PubMed ID: 28386836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.